Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,870.00
-30.00 (-0.43%)
At close: May 2, 2025, 3:30 PM KST
138.54%
Market Cap 332.32B
Revenue (ttm) 87.60B
Net Income (ttm) -9.98B
Shares Out 49.38M
EPS (ttm) -209.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 85,191
Average Volume 210,010
Open 6,870.00
Previous Close 6,900.00
Day's Range 6,840.00 - 7,010.00
52-Week Range 2,715.00 - 13,600.00
Beta n/a
RSI 48.75
Earnings Date May 13, 2025

About Vivozon Pharmaceutical

There is no company description available.

Founded 2002
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 082800
Full Company Profile

Financial Performance

In 2024, Vivozon Pharmaceutical's revenue was 87.60 billion, an increase of 22.83% compared to the previous year's 71.32 billion. Losses were -9.98 billion, 197.3% more than in 2023.

Financial Statements

News

There is no news available yet.